2024
DOI: 10.1016/j.lfs.2024.122472
|View full text |Cite
|
Sign up to set email alerts
|

Calcium sensing receptor: A promising therapeutic target in pulmonary hypertension

Jiwei Zhang,
Qinli Li,
Pu Liao
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
0
1
0
Order By: Relevance
“…In the vasculature, the CaSR is proposed to be expressed in perivascular sensory nerves, VSMCs, and VECs and there is significant evidence that stimulation of the CaSR induces vasorelaxations (Awumey et al., 2008 , 2013 ; Bukoski et al., 1997 ; Carlton‐Carew et al., 2024 ; Greenberg et al., 2017 , 2019 ; Greenberg, Jahan, et al., 2016 ; Greenberg, Shi, et al., 2016 ; Ishioka & Bukoski, 1999 ; Loot et al., 2013 ; Mupanomunda et al., 1998 , 1999 ; Tang et al., 2016 ; Thakore & Ho, 2011 ; Wang & Bukoski, 1998 , 1999 ; Weston et al., 2005 , 2008 ), vasoconstrictions (Li et al., 2011 ; Schepelmann et al., 2016 ; Wonneberger et al., 2000 ), and biphasic responses (Ohanian et al., 2005 ). Possible involvement of the CaSR in excessive vasocontraction or vasodilatation may indicates it is a therapeutic target for cardiovascular conditions such as systemic and pulmonary hypertension and septic shock (Guo et al., 2018 ; Sood et al., 2022 ; Zhang et al., 2024 ).…”
Section: Introductionmentioning
confidence: 99%
“…In the vasculature, the CaSR is proposed to be expressed in perivascular sensory nerves, VSMCs, and VECs and there is significant evidence that stimulation of the CaSR induces vasorelaxations (Awumey et al., 2008 , 2013 ; Bukoski et al., 1997 ; Carlton‐Carew et al., 2024 ; Greenberg et al., 2017 , 2019 ; Greenberg, Jahan, et al., 2016 ; Greenberg, Shi, et al., 2016 ; Ishioka & Bukoski, 1999 ; Loot et al., 2013 ; Mupanomunda et al., 1998 , 1999 ; Tang et al., 2016 ; Thakore & Ho, 2011 ; Wang & Bukoski, 1998 , 1999 ; Weston et al., 2005 , 2008 ), vasoconstrictions (Li et al., 2011 ; Schepelmann et al., 2016 ; Wonneberger et al., 2000 ), and biphasic responses (Ohanian et al., 2005 ). Possible involvement of the CaSR in excessive vasocontraction or vasodilatation may indicates it is a therapeutic target for cardiovascular conditions such as systemic and pulmonary hypertension and septic shock (Guo et al., 2018 ; Sood et al., 2022 ; Zhang et al., 2024 ).…”
Section: Introductionmentioning
confidence: 99%